The Relationship Between pks+ Escherichia coli and Colorectal Cancer: A Review
Authors:
- Bolor UlziitsogtBUBolor Ulziitsogt
- Chuluunbileg BatboldCBChuluunbileg Batbold
- Tsogdulam SumiyabazarTSTsogdulam Sumiyabazar
- Gantogtokh DashjamtsGDGantogtokh Dashjamts
- Yumchinsuren TsedendorjYTYumchinsuren Tsedendorj
- Tegshjargal BadamjavTBTegshjargal Badamjav
- Ganchimeg DondovGDGanchimeg Dondov
- Tulgaa LonjidTLTulgaa Lonjid
- Batbold BatsaikhanBatbold Batsaikhan
Open Access
- 25 March 2026
- journal article
- review article
- Published by American Society for Inclusion, Diversity, and Equity in Healthcare in ASIDE Oncology
- Vol. 1 (2) , 1-10
Abstract
Introduction: According to GLOBOCAN estimates, colorectal cancer (CRC) was the third most common cancer worldwide in 2020, comprising 11% of all cancer diagnoses. Researchers’ interest in CRC development has shifted toward the gastrointestinal microbiome, especially the mutagenicity of pks+ E. coli. Therefore, we aimed to review the current evidence on the relationship between pks+ E. coli and CRC. Method: We reviewed the literature reporting the association between pks+ E. coli and CRC, which was obtained from three databases: PubMed, Google Scholar, and the Cochrane Library, published between January 2021 and January 2026. We used the following keywords for our search strategy: pks, Escherichia coli, and colorectal cancer. Result: As stated in the original studies, the contribution of pks+ E. coli to CRC development was associated with a higher prevalence in the CRC group than in the healthy group. However, these results are inconsistent across the studies. Conclusion: Given the limited evidence, researchers should conduct larger cohort studies to clarify this relationship and identify other factors contributing to the presence of pks+ E. coli, particularly across diverse clinical settings. Furthermore, clinical translation, such as the utilization of screening or therapeutic biomarkers, requires prospective validation and standardized detection methods.Keywords
This publication has 82 references indexed in Scilit:
- Polyketide synthase positive Escherichia coli one‐time measurement in stool is not informative of colorectal cancer risk in a screening settingThe Journal of Pathology, 2024
- Pathogenic Escherichia coli2024
- Role of Diet in Colorectal Cancer IncidenceJAMA Network Open, 2021
- Human gut microbiota/microbiome in health and diseases: a reviewAntonie van Leeuwenhoek, 2020
- Meta‐analysis of 16 studies of the association of alcohol with colorectal cancerInternational Journal of Cancer, 2019
- Cancer‐associated fecal microbial markers in colorectal cancer detectionInternational Journal of Cancer, 2017
- Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal CancerJAMA Oncology, 2017
- Diarrheagenic Escherichia coliBrazilian Journal of Microbiology, 2016
- Familial Risk and Heritability of Cancer Among Twins in Nordic CountriesJAMA, 2016
- Differentiation between Shigella, enteroinvasive Escherichia coli (EIEC) and noninvasive Escherichia coliEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011